Center on Addiction.
Psychology Department, Purchase College, SUNY.
J Clin Child Adolesc Psychol. 2021 Nov-Dec;50(6):874-887. doi: 10.1080/15374416.2020.1716362. Epub 2020 Feb 20.
: This study tested two family-based interventions designed for delivery in usual care: Changing Academic Support in the Home for Adolescents with ADHD (CASH-AA), containing motivational interventions, homework management and schoolwork organization training, and family-school partnership building; and Medication Integration Protocol (MIP), containing ADHD psychoeducation, medication decision-making, and integrated medication management.: This study used a cluster randomized design to test CASH-AA + MIP versus CASH-AA Only for adolescents with ADHD in five sites. Therapists (N = 49) were site clinicians randomized to condition. Clients (N = 145) included 72% males; 42% White Non-Hispanic, 37% Hispanic American, 15% African American, and 6% more than one race; average age was 14.8 years. Fidelity data confirmed protocol adherence and between-condition differentiation.: One-year improvements were observed across conditions in several outcomes. Overall, CASH-AA + MIP produced greater declines in adolescent-report inattentive symptoms and delinquent acts. Similarly, among non-substance users, CASH-AA + MIP clients attended more treatment sessions. In contrast, among substance users, CASH-AA Only clients showed greater declines in caregiver-report hyperactive symptoms and externalizing.: This study provides initial experimental support for family-based ADHD medication decision-making when coupled with academic training in usual care. The treatment protocols, CASH-AA and MIP, showed positive effects in addressing not only ADHD symptoms but also common co-occurring problems, and youth with substance use problems benefitted along with non-using peers.
本研究测试了两种基于家庭的干预措施,旨在常规护理中实施:改变青少年 ADHD 的家庭学术支持(CASH-AA),包含动机干预、家庭作业管理和学校作业组织培训以及家校合作关系建立;以及药物整合协议(MIP),包含 ADHD 心理教育、药物决策和综合药物管理。本研究采用集群随机设计,在五个地点测试 ADHD 青少年的 CASH-AA + MIP 与 CASH-AA 单一疗法。治疗师(N=49)为按条件随机分配的现场临床医生。患者(N=145)包括 72%的男性;42%为白种非西班牙裔,37%为西班牙裔美国人,15%为非裔美国人,6%为多种族;平均年龄为 14.8 岁。可信度数据证实了方案的遵守情况和条件之间的差异。在几个结果中,观察到所有条件在一年内都有改善。总体而言,CASH-AA + MIP 导致青少年自我报告的注意力不集中症状和犯罪行为显著减少。同样,在非药物使用者中,CASH-AA + MIP 患者接受了更多的治疗次数。相比之下,在药物使用者中,CASH-AA 仅患者的照顾者报告的多动症状和外化问题明显减少。本研究为常规护理中结合学术培训的 ADHD 药物决策提供了初步的实验支持。CASH-AA 和 MIP 这两种治疗方案在解决 ADHD 症状以及常见共病问题方面均显示出积极效果,而且药物使用者和非使用者的青少年都受益。